A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation

Human Reproduction

Volumn 11, Issue 5, 1996, Pages 1035-1037

  Ditkoff, Edward C ^a   Sauer, Mark V ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

IVF; Norethindrone acetate; Ovarian suppression

Indexed keywords

ESTRADIOL; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; NORETHISTERONE ACETATE;

ADULT; ARTICLE; BIRTH RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; ESTRADIOL BLOOD LEVEL; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OOCYTE; OVARY CYST; OVULATION INDUCTION; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029970084     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019292     Document Type: Article

References (16)

1. Anderson, R.E., Stein, A.L. et al. (1990) Effects of norethindrone on gonadotropin and ovarian steroid secretion when used for cycle programming during in vitro fertilization. Fertil. Steril., 59, 96-101.
2. Cassidenti, D.L., Sauer, M.V. et al. (1991) Comparison of intermittent and continuous use of a gonadotropin releasing hormone antagonist (Nal-Glu) in in vitro fertilization: a preliminary report. Am. J. Obstet Gynecol., 165, 1790-1794.
3. Ditkoff, E.G., Cassidenti, D.L. et al. (1991) The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. Am. J. Obstet Gynecol., 165, 1811-1817.
4. Franco, J.G., Baruffi, R.L.R. et al. (1995) Semi-programmed ovarian stimulation as the first choice in in-vitro fertilization programmes. Hum. Reprod., 10, 568-571.
5. Gerli, S., Remohi, J. et al. (1989) Programming of ovarian stimulation with norethindrone acetate in IVF/GIFT cycles. Hum. Reprod., 4, 746-748.
6. Gonzalez, P., Maloulm S. et al. (1995) The use of progestins for programming assisted reproductive cycles and gonadotropin-releasing hormone agonist flare-up protocols in older women. Fertil. Steril., 63, 249-251.
7. Hemrika, D.J., Slaats, E.H. et al. (1993) Pulsatile luteinizing hormone patterns in long term oral contraceptive users. J. Clin. Endocrinol. Metab., 77, 420-426.
8. Hughes, J.N., Attalah, M. et al. (1992) Effects of short-term GnRH agonist-human menopausal gonadotrophin stimulation in patients pre-treated with progestogen. Hum. Reprod., 7, 1079-1084.
9. Kemeter, P. and Feichtinger, W. (1989) Experience with a new fixed stimulation protocol without hormone determinations for programmed oocyte retrieval for in-vitro fertilization. Hum. Reprod., 4, 53-58.
10. Neal, G.S., Sultan, K.M. et al. (1993) A dual approach to ovarian suppression using oral contraceptive pills and leuprolide acetate in high responder patients undergoing IVF. Abstract P-065 at the American Fertility Society conjointly with the Canadian Fertility and Andrology Society.
11. Neveu, S., Hedon, B. et al. (1987) Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization. Fertil. Steril., 47, 639-643.
12. Poindexter, A.N. 3rd, Dildy, G.A. et al. (1993) The effects of a long-acting progestin on the hypothalamic-pituitary-ovarian axis in women with normal menstrual cycles. Contraception, 48, 37-45.
13. Porter, R.N., Smith, W. et al. (1984) Induction of ovulation for in-vitro fertilization using buserelin and gonadotropins. Lancet, 2, 1284-1285.
14. Pouly, J.L., Janny, L., Canis, M. et al. (1989) Gamete intrafallopian tube transfer: benefits of programmed stimulation. Fertil. Steril., 52, 1012-1017.
15. Sampaio, M., Serra, V. et al. (1991) Development of ovarian cysts during gonadotrophin-releasing hormone agonists (GnRHa) administration. Hum. Reprod., 6, 194-197.
16. Yen, S.S.C. (1983) Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Fertil. Steril., 29, 257-266.